The mechanism of pristimerin enhances chemosensitivity of cisplatin to conditionally reprogrammed primary lung adenocarcinoma cells
SHI Yi
ZHONG Yan
LIU Xiaohu
KE Zunfu
CHEN Xiao
TANG Yubo
Machine-generated Keywords：
Publication Date：2022-04-10
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 841-847 )